MITOCHONDRIAL CA, NEURONAL AGING AND B-AMYLOID TOXICITY

$209,531P01FY2000AGNIH

University Of Kentucky, Lexington KY

Investigators

Linked publications & trials

Paper 31981008 Paper 31923239 Paper 26837425 Paper 25576397 Paper 25267625 Paper 25151119 Paper 24949886 Paper 24859566 Paper 24355211 Paper 24259517 Paper 24231510 Paper 24120836 Paper 24095978 Paper 23933528 Paper 23872023 Paper 23777706 Paper 23736296 Paper 23044265 Paper 23027708 Paper 22792227 Paper 22495349 Paper 22265986 Paper 21954051 Paper 21756998 Paper 21605052 Paper 21289178 Paper 21280237 Paper 20969723 Paper 20942567 Paper 20936705 Paper 20875800 Paper 20869432 Paper 20648652 Paper 20625939 Paper 20596797 Paper 20427664 Paper 20401186 Paper 20399861 Paper 20362559 Paper 20333275 Paper 20176130 Paper 20164570 Paper 20096337 Paper 20083199 Paper 20061649 Paper 20058169 Paper 20013185 Paper 19854267 Paper 19828810 Paper 19780894 Paper 19777328 Paper 19774677 Paper 19751724 Paper 19686046 Paper 19544029 Paper 19439583 Paper 19393648 Paper 19381594 Paper 19374891 Paper 19288120 Paper 19253051 Paper 19249343 Paper 19211887 Paper 19199029 Paper 19157015 Paper 19072283 Paper 18817763 Paper 18803298 Paper 18762245 Paper 18760351 Paper 18752637 Paper 18722394 Paper 18703168 Paper 18617609 Paper 18602817 Paper 18583063 Paper 18541537 Paper 18494939 Paper 18471936 Paper 18466047 Paper 18439434 Paper 18423227 Paper 18423226 Paper 18325775 Paper 18320305 Paper 18077176 Paper 18075672 Paper 18070881 Paper 17882254 Paper 17851195 Paper 17760844 Paper 17664130 Paper 17626207 Paper 17615071 Paper 17570602 Paper 17522440 Paper 17518533 Paper 17465978 Paper 17433272 Paper 17430248

Abstract

The long-term objectives of this project are to define how intracellular Ca/2+ transport processes are altered by hippocampal neurons during aging and Alzheimer's disease, and to determine the role these changes in Ca/2+ homeostasis have in neurodegeneration. The project's immediate goal is to test the specific hypothesis that a common feature of both neuronal aging and the toxicity of beta-amyloid peptide is that they increase calcium-related stress on mitochondria in hippocampal neurons. The research project will address the following specific aims in order to test various features of the central hypothesis. 1) Test the hypothesis that beta-amyloid toxicity alters the functional balance between various Ca/2+ extrusion and sequestration mechanisms so as to increase the Ca/2+ load mitochondria Ca/2+ transport, increasing the time-averaged exposure of mitochondria to elevations of [Ca/2+]. 3) Evaluate the hypothesis that the likelihood that cytosolic Ca/2+ ions get taken up into mitochondria depends on the route with which the Ca/2+ ions enter the cytosol. 4) Test the hypothesis that a) aging enhances the ability of Ca/2+ ions to induce reactive oxygen species (ROS) production in hippocampal mitochondria, and b) that such Ca/2+-induced production of ROS makes an important contribution of the overall oxidative stress induces by beta-amyloid peptides. 5) Evaluate the hypothesis that aging and beta-amyloid peptides sensitize the mitochondrial permeability transition pore to intramitochondrial Ca/2+ ions. These aims will be investigated using two experimental models. Beta- amyloid toxicity will be studied in rat hippocampal neurons in primary culture, while the effects of aging will be studied in rat hippocampal "zipper" slices. Ca/2+ homeostasis will primary be studied in situ, using a combination of pharmacological, electrophysiological, microfluorimetric, and cell imaging methods. A particular strength of this project is the use of advanced confocal imaging methods to evaluate mitochondrial [Ca/2+] and membrane potentials in situ.

View original record on NIH RePORTER →